tiprankstipranks
Trending News
More News >
Molecular Partners AG (MLLCF)
OTHER OTC:MLLCF

Molecular Partners AG (MLLCF) Similar Stocks

Compare
11 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Molecular Partners AG
$4.05
$175.36M
-1.83
-14.84%
0 Buy
1 Hold
0 Sell
Hold
Idorsia Ltd
CHF4.42
CHF1.10B
-6.62
506.16%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF23.65
CHF472.08M
19.75
178.56%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF12.88
CHF172.13M
-2.51
12.59%
1 Buy
0 Hold
0 Sell
Moderate Buy
RELIEF THERAPEUTICS Holding
CHF1.90
CHF416.60M
-2.04
-44.88%
Xlife Sciences Ltd.
CHF24.20
CHF139.58M
4.49
-6.20%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MLLCF
Molecular Partners AG
3.50
-0.61
-14.84%
CH:IDIA
Idorsia Ltd
4.42
3.69
505.48%
CH:NWRN
Newron Pharmaceuticals SpA
23.65
15.16
178.56%
CH:SANN
Santhera Pharmaceuticals Holding
12.88
1.44
12.59%
CH:RLF
RELIEF THERAPEUTICS Holding
2.26
-1.84
-44.88%
CH:XLS
Xlife Sciences Ltd.
24.20
-1.60
-6.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts